• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估可溶性受体结合型肿瘤坏死因子-α稳定性的物理化学建模方法。

A physicochemical modelling approach for estimating the stability of soluble receptor-bound tumour necrosis factor-alpha.

作者信息

Ramanathan M

机构信息

Department of Pharmaceutics, State University of New York at Buffalo 14260-1200, USA.

出版信息

Cytokine. 1997 Jan;9(1):19-26. doi: 10.1006/cyto.1996.0131.

DOI:10.1006/cyto.1996.0131
PMID:9067092
Abstract

Soluble receptors (sr) can both inhibit and stimulate cytokine bioactivity. The extent to which sr stabilizes the loss of cytokine bioactivity is an important determinant of whether a sr exerts an agonist-like or antagonist-like pharmacological effect. However, the half-life of sr-bound cytokines can be difficult to determine experimentally because methods that disrupt the sr-cytokine complex can cause loss of cytokine bioactivity. The purpose of this study was to test whether a parsimonious pharmacokinetic model in which the sr stabilizes the decay of short-lived cytokines can be used to determine the half-life of tumour necrosis factor-alpha (TNF-alpha) bound to two human urine-derived sr. A mathematical model which assumes cytokine-sr equilibrium, constant total sr concentration and first-order kinetics for loss of cytokine bioactivity was used. In addition, the model assumes that the experimentally observed bioactivity is related to the free cytokine concentration. The authors fitted experimental data reported by Aderka et al. for two TNF-alpha sr [Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) J Exp Med 175:323-329] and estimated the half-life of sr-bound TNF-alpha. The parameter estimates were plausible and comparable to those obtained by other methods and, additionally, the model predicted the unexpected relationship between sr dose and cytokine-free concentration that is observed after 9 days of TNF-alpha exposure.

摘要

可溶性受体(sr)既能抑制也能刺激细胞因子的生物活性。sr稳定细胞因子生物活性丧失的程度是其发挥激动剂样或拮抗剂样药理作用的一个重要决定因素。然而,与sr结合的细胞因子的半衰期可能很难通过实验确定,因为破坏sr - 细胞因子复合物的方法可能会导致细胞因子生物活性丧失。本研究的目的是测试一个简约的药代动力学模型,其中sr稳定短寿命细胞因子的衰变,是否可用于确定与两种人尿源性sr结合的肿瘤坏死因子-α(TNF-α)的半衰期。使用了一个数学模型,该模型假定细胞因子 - sr平衡、总sr浓度恒定以及细胞因子生物活性丧失的一级动力学。此外,该模型假定实验观察到的生物活性与游离细胞因子浓度相关。作者拟合了Aderka等人报告的两种TNF-α sr的实验数据[Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) J Exp Med 175:323 - 329],并估计了与sr结合的TNF-α的半衰期。参数估计是合理的,并且与通过其他方法获得的估计值相当,此外,该模型预测了在TNF-α暴露9天后观察到的sr剂量与无细胞因子浓度之间的意外关系。

相似文献

1
A physicochemical modelling approach for estimating the stability of soluble receptor-bound tumour necrosis factor-alpha.一种用于评估可溶性受体结合型肿瘤坏死因子-α稳定性的物理化学建模方法。
Cytokine. 1997 Jan;9(1):19-26. doi: 10.1006/cyto.1996.0131.
2
In vivo soluble tumor necrosis factor receptor release in OKT3-treated patients. Differential regulation of TNF-sR55 and TNF-sR75.
Transplantation. 1995 May 27;59(10):1470-5. doi: 10.1097/00007890-199505270-00019.
3
Kinetics of circulating TNF-alpha and TNF soluble receptors following surgery in a clinical model of sepsis.脓毒症临床模型中手术后循环肿瘤坏死因子-α及肿瘤坏死因子可溶性受体的动力学
Cytokine. 1996 Dec;8(12):938-43. doi: 10.1006/cyto.1996.0126.
4
A pharmacokinetic approach for evaluating cytokine binding macromolecules as antagonists.
Pharm Res. 1996 Jan;13(1):84-90. doi: 10.1023/a:1016033418207.
5
A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.一种金属蛋白酶抑制剂可阻断人单核细胞中可溶性细胞因子受体的脱落及跨膜细胞因子前体的加工过程。
Cytokine. 1997 May;9(5):340-6. doi: 10.1006/cyto.1996.0174.
6
Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.力竭运动后的全身炎症反应。细胞因子动力学。
Exerc Immunol Rev. 2002;8:6-48.
7
Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.肿瘤坏死因子可溶性受体75:人肺泡巨噬细胞和单核细胞在γ干扰素存在下释放的主要受体形式。
Am J Respir Cell Mol Biol. 1996 Mar;14(3):279-87. doi: 10.1165/ajrcmb.14.3.8845179.
8
Soluble receptors and cytokine antagonists in human milk.人乳中的可溶性受体和细胞因子拮抗剂。
Pediatr Res. 1996 Dec;40(6):839-44. doi: 10.1203/00006450-199612000-00011.
9
Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.两种促炎细胞因子释放抑制剂,即白细胞介素-10和白细胞介素-4,对培养的单核细胞释放可溶性p75肿瘤坏死因子受体具有相反的作用。
Eur J Immunol. 1994 Nov;24(11):2699-705. doi: 10.1002/eji.1830241119.
10
Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin.紫外线照射的人体皮肤中同种异体抗原呈递受抑制,肿瘤坏死因子-α、白细胞介素-1、白细胞介素-1受体拮抗剂、白细胞介素-10增加,且肿瘤坏死因子受体发生调节。
J Invest Dermatol. 1999 May;112(5):692-8. doi: 10.1046/j.1523-1747.1999.00570.x.

引用本文的文献

1
Digestion assays in allergenicity assessment of transgenic proteins.转基因蛋白致敏性评估中的消化试验
Environ Health Perspect. 2006 Aug;114(8):1154-7. doi: 10.1289/ehp.8803.